Australian wages rose at a steady pace in the third quarter with the public sector driving the gains, a solid result that, ...
Diamond Hill's Long-Short Strategy Q3 review. See how AI is driving markets, our performance vs. benchmarks, and key stock ...
Explore the Artisan Floating Rate Fund's Q3 2025 performance. Discover how our high-conviction philosophy and focus on ...
Analysts see demand for high-grade AI hardware from Nvidia increasing in the coming quarters, staying upbeat even as ...
Among the headline contributors, Xmark Affiliates delivered 42 bonuses, balancing coverage across English-speaking markets ...
OKLO's latest quarterly miss and a sharp stock slide raise fresh questions about its valuation and near-term outlook.
The company reported revenue exceeding EUR 63 million for the first nine months of 2025, representing a YoY increase of 8.7%. EBITDA amounted to nearly EUR 23 million, representing a YoY increase of ...
Cadillac Escalade sales grew 29 percent to 11,332 units during Q3 2025, outpacing Lincoln Navigator, Infiniti QX80, Lexus LX, ...
C3is ( CISS 1.19%) delivered sharply improved net income and EBITDA, despite a substantial decline in voyage revenues due to extended Aframax tanker downtime from dry docking. Management highlighted ...
TipRanks on MSN
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus
Pavmed ( ($PAVM) ) has released its Q3 earnings. Here is a breakdown of the information Pavmed presented to its investors. Pavmed Inc. is a life ...
TipRanks on MSN
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials
Io Biotech, Inc. ( (IOBT) ) has released its Q3 earnings. Here is a breakdown of the information Io Biotech, Inc. presented to its investors.Meet Your ETF AI Analyst Discover how TipRanks' ETF AI ...
Firefly surprised investors with faster-than-expected sales growth in Q3 2025. Firefly then added to the pleasant surprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results